kratom research

Media Drops Ball on Kratom Reporting After Ole Miss Deaths

If you have more examples of media disinformation about kratom, please leave a link and a comment in the comment section below Two students at the University of Mississippi were found dead on September 21, 2026. A media firestorm resulted, and several outlets blamed kratom that was supposedly found near the bodies of the students. …

Media Drops Ball on Kratom Reporting After Ole Miss Deaths Read More »

Gay Porn Star Dies with Alcohol, Mitragynine in His Blood After Prolonged Multi-Substance Bender

“Styles had been on a ‘bender of various substances for a prolonged time’ before his death, the report noted. His parents had been checking on him hourly. He was last seen alive around 3 p.m. and was later discovered by his parents on August 20.” The above quote from an US Magazine article provides critical …

Gay Porn Star Dies with Alcohol, Mitragynine in His Blood After Prolonged Multi-Substance Bender Read More »

DEA Emergency Scheduling of Mitragynine-Pseudoindoxyl Could Ban Kratom Containing Trace Amounts of the Molecule

Notice #DEA-1571 (Federal Register Docket #2026-13581) intends to ban mitragynine pseudoindoxyl with no legal threshold that allows for naturally occurring trace amounts in drying kratom leaves. AKA asks comedian Joe Rogan for help. Two Notices of Intent related to kratom alkaloids were filed by the Drug Enforcement Administration (DEA) on July 1, 2026. One, titled …

DEA Emergency Scheduling of Mitragynine-Pseudoindoxyl Could Ban Kratom Containing Trace Amounts of the Molecule Read More »

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition

Tonight at 11:59 PM, the Department of Health and Human Services (HHS) will close comments on the notice “Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information“. The notice asks for specific information and scientific evidence about the threshold of 7-OH that should be allowable in kratom products. However, many …

Last Day to Comment on 7-OH Schedule I Placement; Hamilton Morris, Carl Hart Speak Out in Opposition Read More »

Arizona Kratom Gummy Case Leaves Key Questions Unanswered

A recent case involving a 27-year-old Arizona woman who reportedly suffered heart failure after consuming kratom gummies has drawn national attention. The woman reportedly took the gummies for leg pain and only took them for one week. While the incident has been widely reported, many of the most important details remain unknown. One of the …

Arizona Kratom Gummy Case Leaves Key Questions Unanswered Read More »

Fallout of the Kansas and Tennessee Kratom Bans

When prohibition is enacted, the consequences rarely unfold in the neat, orderly way lawmakers imagine. Just two weeks underway, the July 1 kratom bans in Kansas and Tennessee offer a real‑time case study in how criminalization can destabilize entire communities overnight. In Kansas, the decision to classify kratom and 7‑hydroxymitragynine (7-OH) as Schedule I substances …

Fallout of the Kansas and Tennessee Kratom Bans Read More »

Scientists Find Kratom Alkaloids in Products Marketed as Kava in Alabama

In a study published June 30 in Clinical Toxicology, scientists found mitragynine, 7-hydroxymitragynine, and mitragynine-pseudoindoxyl in three liquid shot products being sold as “kava” in Alabama. Alabama law specifically lists mitragynine and 7-hydroxymitragynine as Schedule I controlled substances. Though mitragynine-pseudoindoxyl is not specifically listed as a controlled substance in the state, it is controlled as …

Scientists Find Kratom Alkaloids in Products Marketed as Kava in Alabama Read More »

NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status

On June 1, the National Institutes of Health (NIH) announced that mitragynine, the most abundant alkaloid in kratom, has been cleared as an Investigational New Drug (IND). With IND status, scientists at University of Florida are now authorized to study the effects of pure mitragynine in human subjects. National Institute on Drug Abuse (NIDA) Director …

NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status Read More »

“Kratom-Related Exposures” Reported to Poison Control Increase to 3,434 in 2025

Keep in Mind: Despite news media and other nefarious actors’ exaggerations, and despite millions of informed adults using kratom in moderation with net benefits, risks of kratom use are real. Kratom should not be consumed in high doses or with various other substances, including alcohol, Benedryl, Tylenol, opioids, or multiple prescription and over-the-counter drugs. Kratom …

“Kratom-Related Exposures” Reported to Poison Control Increase to 3,434 in 2025 Read More »

FDA Study on Kratom Published

A long-awaited kratom clinical study conducted by the U.S. Food and Drug Administration (FDA) has been published in the Journal of Clinical Psychopharmacology. The pilot study (defined as “a preliminary investigation designed to test the feasibility and design of a larger, more comprehensive study”) involved healthy adult participants who were administered an ascending dose of …

FDA Study on Kratom Published Read More »